Skip to main content

2024 Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Nicole McNeer, MD, PhD

Executive Medical Director
Syndax Pharmaceuticals, Inc.

Poster(s):

157: Pharmacokinetics & Exposure-Response Analyses of Revumenib Support Dosing in a Broad Population of Patients With Relapsed/Refractory Acute Leukemias

Monday, September 9, 2024
5:00 PM – 7:00 PM ET